Tiziana Life Sciences (TILS)

Company name:Tiziana Life Sciences Plc
EPIC:TILSTrading Currency:GBX
Market Segment:SSX3Share Type:DE
WWW Address:http://www.tizianalifesciences.com/Description:ORD 3P
 Price Price Change [%] Bid Ask Open High Low Volume
 58.50 images.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 45.00 60.00 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 113.85 194.61 -0.04 -12.00 - - - 58.50 - 47.50

Tiziana Life Sciences Key Figures

(at previous day's close)
Market Cap.113.85m
Shares In Issue194.61m
Prev. Close58.50
PE Ratio- 
Dividend Yield-%
EPS - basic-12.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-4.78p
Return On Equity (ROE)-44.52%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-122.22%
Dividends PS Growth Rate-%
Net Debt-42.16m
Gross Gearing11.70%
Quick Assets51.41m
Net Working Capital45.56m
Intangibles / Fixed Assets99.72%
Turnover PS-p
Pre-Tax Profit PS-11.34p
Retained Profit PS-10.46p
Cash PS24.78p
Net Cash PS21.77p
Net Tangible Asset Value PS *23.30p
Net Asset Value PS23.49p
Spread15.00 (25.00%) 

Tiziana Life Sciences Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Tiziana Life Sciences Historic Returns

Sorry No Data Available

Tiziana Life Sciences Key Management Ratios

Tiziana Life Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.25 
Tobin's Q Ratio (excl. intangibles)4.31 
Dividend Yield-%
Market-to-Book Ratio2.49 
Price-to-Pre-Tax Profit PS-5.16 
Price-to-Retained Profit PS-5.60 
Price-to-Cash Flow PS-12.25 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS2.51 
Price-to-Cash PS2.36 
Net Working Capital PS23.41 
Price Pct to Working Capital PS2.50%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Tiziana Life Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio0.46%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-81.44%
Net Gearing (excl. Intangibles)-82.01%
Gross Gearing11.70%
Gross Gearing (excl. Intangibles)11.78%
Gearing Under 1 Year11.29%
Gearing Under 1 Year (excl. Intgbl)11.37%
(Liquidity Ratios)
Net Working Capital to Total Assets88.01%
Current Ratio8.79 
Quick Ratio (Acid Test)8.79 
Liquidity Ratio8.25 
Cash & Equiv/Current Assets93.80%
(Solvency Ratios)
Enterprise Value65.84m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.05 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.27 
Total Debt6.06m
Total Debt/Net Current Assets0.13%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

Tiziana Life Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-48.05%
Return On Assets (ROA)-75.96%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-44.52%
Return On Investment (ROI)-96.55%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Tiziana Life Sciences Dividends

Sorry No Data Available

Tiziana Life Sciences Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
pre tax profit-8.26--7.45--7.85--22.07-m
attributable profit-6.77--6.00--7.31--20.35-m
retained profit-6.77--6.00--7.31--20.35-m
eps - basic (p)-6.40 -4.70 -5.40 -12.00 
eps - diluted (p)-6.40 -4.70 -5.40 -12.00 
dividends per share- - - - 

Tiziana Life Sciences Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
fixed assets fixed assets0.020.98%0.010.11%0.010.28%0.000.00%m
intangibles intangibles--%--%0.3318.20%0.360.69%m
fixed investments fixed investments--%--%0.2212.00%--%m
current assets - other current assets - other0.2211.85%0.223.99%--%--%m
stocks stocks--%--%--%--%m
debtors debtors1.5584.54%1.0519.28%1.1061.06%3.196.16%m
cash & securities cash & securities0.052.62%4.1776.62%0.158.46%48.2293.14%m
creditors - short creditors - short3.51191.92%5.0392.44%5.58308.46%5.8511.29%m
creditors - long creditors - long--%--%0.4122.73%0.210.41%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves-1.68-91.92%0.417.56%-4.18-231.19%45.7188.30%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Tiziana Life Sciences Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF-5.85-3.41-5.33-9.30m
Pre-Financing CF-5.85-3.41-5.33-9.40m
Retained CF-4.664.12-4.0148.06m

Tiziana Life Sciences Brokers

Broker infomation is not available for this class of share.
Your Recent History
Tiziana Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220927 11:38:19